emeis (EMEIS) Q3 2025 TU earnings summary

Executive summary

• Q3 2025 saw continued improvement in occupancy rates, reaching 88% (up 1.8 points YoY), with strong momentum in Germany and France and all geographies contributing to growth.

• Organic revenue growth was 6.4% YTD, accelerating to 7% in Q3, driven by higher occupancy and favorable pricing.

• All regions posted occupancy and revenue gains, with Northern Europe and Southern Europe showing notable strength.

• Disposal plan exceeded €2.1 billion between July 2022 and December 2025, surpassing the initial €1.5 billion target.

• New facility openings, especially in the Netherlands and Spain, contributed to occupancy and revenue growth.

Financial highlights

• Q3 2025 revenue was €1,480 million, up 5.6% YoY (+7.0% organic); YTD revenue reached €4,388 million, up 5.2% (+6.4% organic).

• Nursing homes segment posted 8.5% organic growth over nine months; clinics and other activities grew 2.7%.

• Price effect contributed 3.8% to organic growth YTD, with Q3 price effect around 4%.

• International operations saw robust organic growth: Northern Europe +10.9%, Central Europe +7.3%, Southern Europe & Latam +10.2%.

• Ramp-up of new facilities contributed 1% to organic growth.

Outlook and guidance

• 2025 EBITDA/EBITDAR expected to increase by 15%-18% like-for-like versus 2024 (base: €740 million EBITDA in 2024).

• Midterm outlook (2024-2028): average annual revenue growth of 4%-5% and EBITDA/EBITDAR growth of 12%-16% like-for-like.

• Growth in operating margin expected as occupancy rates normalize above 90% and price effects are captured.

• Medium-term growth supported by demographic trends and structural supply shortages in care markets.